Protea Biosciences Group, Inc. and Proteos, Inc. announced that they have entered into a joint co-marketing agreement. This mutual partnership allows Protea to combine Proteos' protein production capabilities alongside Protea's proprietary bioanalytical services, and allows Proteos to market and promote Protea's proprietary bioanalytical services with their custom protein production services. Recent advancements in recombinant protein production technologies, combined with an ever-increasing understanding of biology, are discovering novel proteins at a rapid pace. These novel proteins are useful in a wide variety of biotherapeutic, industrial and diagnostic applications. With these advances comes the need for seamlessly integrating quantitative analysis of these proteins. The combined availability of the Protea and Proteos technology platforms will benefit companies and research institutions by streamlining their project development cycles. Both companies plan to actively co-market their respective capabilities to the biopharmaceutical, biotechnology, life science and academic sectors.